Canagliflozin vs Nivolumab

## Canagliflozin vs Nivolumab: Overview

This comparison examines the pharmacological differences between **Canagliflozin** and **Nivolumab**.

## Mechanism of Action

**Canagliflozin**: Selective SGLT2 inhibitor reducing renal glucose reabsorption and lowering blood glucose.

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

## Pharmacokinetics

**Half-life**: Canagliflozin — 10.6 hours; Nivolumab — 27 days.

## Chemical Properties

**Molecular Formula**: Canagliflozin — C24H25FO5S; Nivolumab — N/A.

**Molecular Weight**: Canagliflozin — 444.5170 g/mol; Nivolumab — N/A.

**Type**: Canagliflozin — Small molecule; Nivolumab — Antibody.